Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 567

1.

Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.

Ellberg C, Jernström H, Broberg P, Borg A, Olsson H.

Genes Chromosomes Cancer. 2014 Sep 23. doi: 10.1002/gcc.22217. [Epub ahead of print]

PMID:
25251729
[PubMed - as supplied by publisher]
2.

The effect on melanoma risk of genes previously associated with telomere length.

Iles MM, Bishop DT, Taylor JC, Hayward NK, Brossard M, Cust AE, Dunning AM, Lee JE, Moses EK, Akslen LA; AMFS Investigators, Andresen PA, Avril MF, Azizi E, Scarrà GB, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Harland M, Helsing P, Hočevar M, Höiom V; IBD investigators, Ingvar C, Kanetsky PA, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Martin NG, Molven A, Montgomery GW, Novaković S, Olsson H, Puig S, Puig-Butille JA; QMEGA and QTWIN Investigators, Radford-Smith GL, Randerson-Moor J; SDH Study Group, van der Stoep N, van Doorn R, Whiteman DC, MacGregor S, Pooley KA, Ward SV, Mann GJ, Amos CI, Pharoah PD, Demenais F, Law MH, Newton Bishop JA, Barrett JH; GenoMEL Consortium.

J Natl Cancer Inst. 2014 Sep 17;106(10). pii: dju267. doi: 10.1093/jnci/dju267. Print 2014 Oct.

PMID:
25231748
[PubMed - in process]
Free PMC Article
3.

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Jewell R, Elliott F, Laye J, Nsengimana J, Davies J, Walker C, Conway C, Mitra A, Harland M, Cook MG, Boon A, Storr S, Safuan S, Martin SG, Jirström K, Olsson H, Ingvar C, Lauss M, Bishop T, Jönsson G, Newton-Bishop J.

Pigment Cell Melanoma Res. 2014 Sep 15. doi: 10.1111/pcmr.12315. [Epub ahead of print]

PMID:
25220403
[PubMed - as supplied by publisher]
4.

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.

Nilsson MP, Hartman L, Kristoffersson U, Johannsson OT, Borg A, Henriksson K, Lanke E, Olsson H, Loman N.

Breast Cancer Res Treat. 2014 Oct;147(3):571-8. doi: 10.1007/s10549-014-3115-3. Epub 2014 Sep 4.

PMID:
25187270
[PubMed - in process]
Free PMC Article
5.

Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.

Björner S, Fitzpatrick PA, Li Y, Allred C, Howell A, Ringberg A, Olsson H, Miller CJ, Axelson H, Landberg G.

PLoS One. 2014 Aug 14;9(8):e105099. doi: 10.1371/journal.pone.0105099. eCollection 2014.

PMID:
25122196
[PubMed - in process]
Free PMC Article
6.

Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions.

Barrett JH, Taylor JC, Bright C, Harland M, Dunning AM, Akslen LA, Andresen PA, Avril MF, Azizi E, Bianchi Scarrà G, Brossard M, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Helsing P, Hočevar M, Höiom V, Ingvar C, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Molven A, Novaković S, Olsson H, Puig S, Puig-Butille JA, van der Stoep N, van Doorn R, van Workum W, Goldstein AM, Kanetsky PA, Pharoah PD, Demenais F, Hayward NK, Newton Bishop JA, Bishop DT, Iles MM; on behalf of the GenoMEL Consortium.

Int J Cancer. 2014 Jul 31. doi: 10.1002/ijc.29099. [Epub ahead of print]

PMID:
25077817
[PubMed - as supplied by publisher]
7.

A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging.

Sugihara Y, Végvári A, Welinder C, Jönsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, Wieslander E, Laurell T, Rezeli M, Jansson B, Nishimura T, Fehniger TE, Baldetorp B, Marko-Varga G.

Proteomics. 2014 Sep;14(17-18):1963-70. doi: 10.1002/pmic.201300476. Epub 2014 Aug 18.

PMID:
25044963
[PubMed - in process]
8.

Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case-control study 1988-2009.

Wagner P, Alvegård T, Ranstam J, Rydholm A, Vult von Steyern F, Olsson H.

Cancer Causes Control. 2014 Sep;25(9):1167-77. doi: 10.1007/s10552-014-0420-4. Epub 2014 Jul 18.

PMID:
25034461
[PubMed - in process]
9.

Primary Melanoma Tumors from CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass.

Staaf J, Harbst K, Lauss M, Ringnér M, Måsbäck A, Howlin J, Jirström K, Harland M, Zebary A, Palmer JM, Ingvar C, Olsson H, Newton-Bishop J, Hansson J, Hayward N, Gruis N, Jönsson G; the Melanoma Genetics Consortium (GenoMEL).

J Invest Dermatol. 2014 Jul 7. doi: 10.1038/jid.2014.272. [Epub ahead of print] No abstract available.

PMID:
24999598
[PubMed - as supplied by publisher]
10.

[Swedish medical research does not need more control].

Andersén P, Bäckström T, Dahlquist G, Damber JE, Engström-Laurent A, Gustafson Y, Hjemdahl P, Korsgren O, Olsson H, Wiberg M, Widmark A.

Lakartidningen. 2014 May 27-Jun 10;111(22-23):980-1. Swedish. No abstract available.

PMID:
24946479
[PubMed - indexed for MEDLINE]
11.

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Helgadottir H, Höiom V, Jönsson G, Tuominen R, Ingvar C, Borg A, Olsson H, Hansson J.

J Med Genet. 2014 Aug;51(8):545-52. doi: 10.1136/jmedgenet-2014-102320. Epub 2014 Jun 16.

PMID:
24935963
[PubMed - in process]
Free PMC Article
12.

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.

Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, Adami HO, Askling J, Smedby KE.

BMC Cancer. 2014 Jun 2;14:391. doi: 10.1186/1471-2407-14-391.

PMID:
24890520
[PubMed - in process]
Free PMC Article
13.

Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival.

Gordon D, Smedby KE, Schultz I, Olsson H, Ingvar C, Hansson J, Gillgren P.

Ann Surg Oncol. 2014 Oct;21(11):3386-94. doi: 10.1245/s10434-014-3744-0. Epub 2014 May 28.

PMID:
24866434
[PubMed - in process]
14.

Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line.

Olsson H, Sandström R, Grundemar L.

J Clin Pharmacol. 2014 May 7. doi: 10.1002/jcph.328. [Epub ahead of print]

PMID:
24800998
[PubMed - as supplied by publisher]
15.

Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Shabo I, Olsson H, Elkarim R, Sun XF, Svanvik J.

Cancer Microenviron. 2014 Aug;7(1-2):61-9. doi: 10.1007/s12307-014-0145-7. Epub 2014 Apr 28.

PMID:
24771466
[PubMed]
Free PMC Article
16.

Investigation of a putative melanoma susceptibility locus at chromosome 3q29.

Tuominen R, Jönsson G, Enerbäck C, Appelqvist F, Olsson H, Ingvar C, Hansson J, Höiom V.

Cancer Genet. 2014 Mar;207(3):70-4. doi: 10.1016/j.cancergen.2014.02.007. Epub 2014 Feb 21.

PMID:
24721441
[PubMed - indexed for MEDLINE]
17.

Avoidance of sun exposure is a risk factor for all-cause mortality: results from the Melanoma in Southern Sweden cohort.

Lindqvist PG, Epstein E, Landin-Olsson M, Ingvar C, Nielsen K, Stenbeck M, Olsson H.

J Intern Med. 2014 Jul;276(1):77-86. doi: 10.1111/joim.12251. Epub 2014 Apr 23.

PMID:
24697969
[PubMed - indexed for MEDLINE]
18.

[Camptocormia and pleurothotonus: rare side effects of neuroleptics].

Olsson H.

Lakartidningen. 2014 Feb 19-25;111(8):337-9. Swedish. No abstract available.

PMID:
24669454
[PubMed - indexed for MEDLINE]
19.

[People with limited autonomy and decision-making ability--Health and Social Care Inspectorate should take a stand].

Olsson H, Thuresson K.

Lakartidningen. 2014 Feb 19-25;111(8):316-7. Swedish. No abstract available.

PMID:
24669449
[PubMed - indexed for MEDLINE]
20.

Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results.

Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, Sesso HD, Snyder K, Swerdlow AJ; European Rare Cancer Study Group, Trichopoulos D, Ursin G, van den Brandt PA, Van Den Eeden SK, Weiderpass E, Willett WC, Ewertz M, Thomas DB.

J Natl Cancer Inst. 2014 Mar;106(3):djt465. doi: 10.1093/jnci/djt465. Epub 2014 Feb 19. Erratum in: J Natl Cancer Inst. 2014 May;106(5):dju117.

PMID:
24552677
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk